Pharmaceutical Products Companies By Gross Profit
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Gross Profit
| Gross Profit | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | AAPG | Ascentage Pharma Group | 0.15 | 3.59 | 0.55 | ||
| 2 | TLX | Telix Pharmaceuticals Limited | 0.05 | 3.26 | 0.16 | ||
| 3 | LSBPW | LakeShore Biopharma Co, | 0.04 | 23.10 | 1.01 | ||
| 4 | MIRM | Mirum Pharmaceuticals | 0.08 | 2.52 | 0.21 | ||
| 5 | MNKD | MannKind Corp | (0.22) | 1.87 | (0.41) | ||
| 6 | MDGL | Madrigal Pharmaceuticals | 0.04 | 4.30 | 0.17 | ||
| 7 | VCEL | Vericel Corp Ord | (0.13) | 2.57 | (0.32) | ||
| 8 | DVAX | Dynavax Technologies | 0.08 | 1.50 | 0.12 | ||
| 9 | MAZE | Maze Therapeutics, Common | (0.17) | 5.14 | (0.86) | ||
| 10 | ME | 23Andme Holding Co | (0.15) | 11.99 | (1.83) | ||
| 11 | MRVI | Maravai Lifesciences Holdings | (0.22) | 5.63 | (1.21) | ||
| 12 | ZYBT | Zhengye Biotechnology Holding | 0.05 | 8.90 | 0.45 | ||
| 13 | MTEX | Mannatech Incorporated | (0.16) | 4.25 | (0.66) | ||
| 14 | DTIL | Precision BioSciences | 0.05 | 6.40 | 0.35 | ||
| 15 | EQ | Equillium | (0.08) | 7.94 | (0.65) | ||
| 16 | XOMAP | XOMA Corp | 0.05 | 0.58 | 0.03 | ||
| 17 | XOMAO | XOMA Corporation | 0.08 | 0.27 | 0.02 | ||
| 18 | MRUS | Merus BV | 0.05 | 2.66 | 0.14 | ||
| 19 | MGTX | MeiraGTx Holdings PLC | 0.09 | 4.97 | 0.47 | ||
| 20 | VERV | Verve Therapeutics | 0.01 | 5.46 | 0.05 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.